Tower Research Capital »

Gyre Therapeutics Incorporated shares owned by Tower Research Capital

Quarter-by-quarter ownership of Gyre Therapeutics Incorporated (GYRE) shares owned by Tower Research Capital from 13F filings

Historical chart of Tower Research Capital investment in Gyre Therapeutics Incorporated

Tip: Access up to 7 years of quarterly data

All positions including Gyre Therapeutics Incorporated held by Tower Research Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Gyre Therapeutics Incorporated by Tower Research Capital

Quarter filed Position value Share count Share price at filing
2024-03-31 $50k 2.9k 17.48

More positions owned by Tower Research Capital

Spdr S&p 500 Etf Tr Tr Unit (SPY)
Microsoft Corporation (MSFT)
NVIDIA Corporation (NVDA)
Apple (AAPL)
Amazon (AMZN)
Meta Platforms Cl A (META)
Ishares Tr Russell 2000 Etf (IWM)
Alphabet Cap Stk Cl A (GOOGL)
Broadcom (AVGO)
Alphabet Cap Stk Cl C (GOOG)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Spdr Dow Jones Indl Average Ut Ser 1 (DIA)
Visa Com Cl A (V)
Ishares Tr Core S&p500 Etf (IVV)
Home Depot (HD)

View all positions for Tower Research Capital

Top funds holding Gyre Therapeutics Incorporated

Vanguard Group
BlackRock
Geode Capital Management
Millennium Management
Goldman Sachs Group
State Street Corporation
Jane Street
Marshall Wace
Northern Trust
Jpmorgan Chase & Co
Balyasny Asset Management
Citigroup
Qube Research & Technologies
Morgan Stanley
Tower Research Capital

View all funds holding Gyre Therapeutics Incorporated